These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 1591700)
1. bcr breakpoint location in Spanish patients with chronic myelogenous leukemia. Valiente A; Benitez J; Prieto E Cancer Genet Cytogenet; 1992 May; 60(1):108-9. PubMed ID: 1591700 [No Abstract] [Full Text] [Related]
2. ABL gene fuses BCR during t(20;22) results in Philadelphia-negative, but BCR/ABL-positive chronic myeloid leukemia. Ito Y; Shimamoto T; Kuriyama Y; Nakajima A; Sumi M; Watanabe Y; Beppu H; Ohtsubo K; Ohyashiki K Leukemia; 2002 May; 16(5):951-2. PubMed ID: 11986960 [No Abstract] [Full Text] [Related]
3. New type of Bcr/Abl junction in Philadelphia chromosome-positive chronic myelogenous leukemia. Saglio G; Guerrasio A; Rosso C; Zaccaria A; Tassinari A; Serra A; Rege-Cambrin G; Mazza U; Gavosto F Blood; 1990 Nov; 76(9):1819-24. PubMed ID: 2224129 [TBL] [Abstract][Full Text] [Related]
4. Lack of bcr rearrangement in juvenile chronic myeloid leukemia. Toren A; Mandel M; Amariglio N; Hakim Y; Brok-Simoni F; Rechavi G; Neumann Y; Ramot B Med Pediatr Oncol; 1991; 19(6):493-5. PubMed ID: 1683680 [TBL] [Abstract][Full Text] [Related]
5. A new chromosomal breakpoint in Ph positive, bcr negative chronic myelogenous leukemia. Report of a case. Negrini M; Tallarico A; Pazzi I; Castagnoli A; Cuneo A; Castoldi GL Cancer Genet Cytogenet; 1992 Jul; 61(1):11-3. PubMed ID: 1353407 [TBL] [Abstract][Full Text] [Related]
6. Study of the BCR/ABL rearrangement in patients with two Philadelphia chromosomes. González FA; Villegas A; Asenjo S; Alvarez A; Ferro MT; Resino M Cancer Genet Cytogenet; 1993 Oct; 70(2):153-4. PubMed ID: 8242601 [No Abstract] [Full Text] [Related]
7. Frequencies of the breakpoint cluster region types of the BCR/ABL fusion gene in Mexican Mestizo patients with chronic myelogenous leukemia. Ruiz-Argüelles GJ; Garcés-Eisele J; Reyes-Núñez V; Ruiz-Delgado GJ Rev Invest Clin; 2004; 56(5):605-8. PubMed ID: 15776864 [TBL] [Abstract][Full Text] [Related]
8. BCR breakpoint location and prognosis in CML. Leibowitz D Blood; 1989 May; 73(6):1745-6. PubMed ID: 2653462 [No Abstract] [Full Text] [Related]
9. Paternal origin of the rearranged major breakpoint cluster region in chronic myeloid leukemia. Litz CE; Copenhaver CM Blood; 1994 Jun; 83(12):3445-8. PubMed ID: 8204872 [TBL] [Abstract][Full Text] [Related]
10. Methylation of the major breakpoint cluster region (M-bcr) in Philadelphia-positive CML. Mills KI; Sproul AM; Burnett AK Leukemia; 1993 May; 7(5):707-11. PubMed ID: 7683349 [TBL] [Abstract][Full Text] [Related]
11. Cytogenetic response to alpha-interferon is predicted in early chronic phase chronic myeloid leukemia by M-bcr breakpoint location. Elliott SL; Taylor KM; Taylor DL; Rodwell RL; Williams BF; Shuttlewood MM; Wright SJ; Eliadis PE; Bunce IH; Frost TJ Leukemia; 1995 Jun; 9(6):946-50. PubMed ID: 7596182 [TBL] [Abstract][Full Text] [Related]
12. Duplication of small segments within the major breakpoint cluster region in chronic myelogenous leukemia. Litz CE; McClure JS; Copenhaver CM; Brunning RD Blood; 1993 Mar; 81(6):1567-72. PubMed ID: 8453102 [TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of Philadelphia-positive childhood chronic myeloid leukemia. Fioretos T; Heim S; Garwicz S; Ludvigsson J; Mitelman F Leukemia; 1992 Jul; 6(7):723-5. PubMed ID: 1625493 [TBL] [Abstract][Full Text] [Related]
14. Molecular and cytogenetic characterization of a novel translocation t(4;22) involving the breakpoint cluster region and platelet-derived growth factor receptor-alpha genes in a patient with atypical chronic myeloid leukemia. Safley AM; Sebastian S; Collins TS; Tirado CA; Stenzel TT; Gong JZ; Goodman BK Genes Chromosomes Cancer; 2004 May; 40(1):44-50. PubMed ID: 15034867 [TBL] [Abstract][Full Text] [Related]
15. Clinical impact of breakpoint position within M-bcr in chronic myeloid leukemia. Fioretos T; Nilsson PG; Aman P; Heim S; Kristoffersson U; Malm C; Simonsson B; Turesson I; Mitelman F Leukemia; 1993 Aug; 7(8):1225-31. PubMed ID: 8350622 [TBL] [Abstract][Full Text] [Related]
16. Analysis of the clinical relevance of the breakpoint location within M-BCR and the type of chimeric mRNA in chronic myelogenous leukemia. Rozman C; Urbano-Ispizua A; Cervantes F; Rozman M; Colomer D; Féliz P; Pujades A; Vives Corrons JL Leukemia; 1995 Jun; 9(6):1104-7. PubMed ID: 7596178 [TBL] [Abstract][Full Text] [Related]
17. Relationship between M-BCR breakpoint position in blast crisis and length of chronic phase in chronic myeloid leukemia. Stein B; Dobrovic A Blood; 1992 Jun; 79(11):3097-8. PubMed ID: 1586754 [No Abstract] [Full Text] [Related]
18. Loss of heterozygosity at D3S2 locus of short arm of chromosome 3 in chronic myelogenous leukemia. Tanaka K; Mansoor AM; Shigeta C; Oguma N; Kamada N Cancer Genet Cytogenet; 1992 Jul; 61(1):42-5. PubMed ID: 1353408 [TBL] [Abstract][Full Text] [Related]
19. A fourth case of BCR-FGFR1 positive CML-like disease with t(8;22) translocation showing an extensive deletion on the derivative chromosome 8p. Pini M; Gottardi E; Scaravaglio P; Giugliano E; Libener R; Baraldi A; Muzio A; Cornaglia E; Saglio G; Levis A Hematol J; 2002; 3(6):315-6. PubMed ID: 12522455 [No Abstract] [Full Text] [Related]
20. Cancer genetics. Imprinting in leukaemia. Reik W Nature; 1992 Oct; 359(6394):362-3. PubMed ID: 1406944 [No Abstract] [Full Text] [Related] [Next] [New Search]